Reactivation of the tumor suppressor SPARC in bladder cancer by verteporfin

被引：0
|
作者：
Said, Neveen A.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P220
引用
收藏
页数：2
相关论文
共 50 条
  • [21] IGFBP-RP1 EXPRESSION IS DECREASED IN BLADDER CANCER - POSSIBLE BLADDER TUMOR SUPPRESSOR
    Yasumoto, Hiroaki
    Hiraki, Miho
    Arichi, Naoko
    Mitsui, Yozo
    Hiraoka, Takeo
    Wake, Koji
    Sumura, Masahiro
    Honda, Satoshi
    Shiina, Hiroaki
    Igawa, Mikio
    Ribeiro-Filho, Leopoldo
    Srougi, Miguel
    JOURNAL OF UROLOGY, 2010, 183 (04): : E304 - E305
  • [22] Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer
    Carlos Cordon-Cardo
    Joel Sheinfeld
    World Journal of Urology, 1997, 15 : 112 - 119
  • [23] 15-Hydroxyprostagladin Dehydrogenase (PGDH) is a potential bladder cancer tumor suppressor
    Tseng-Rogenski, Stephanie S.
    Liebert, Monica
    CANCER RESEARCH, 2006, 66 (08)
  • [24] miR-1 is a putative tumor suppressor gene for urothelial bladder cancer
    Wille, Mark A.
    Jayram, Gautam
    Large, Michael
    Wiltz, Aimee
    Steinberg, Gary D.
    Robinson, Victoria L.
    CANCER RESEARCH, 2010, 70
  • [25] A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer
    Frank Christoph
    Stefan Hinz
    Carsten Kempkensteffen
    Steffen Weikert
    Hans Krause
    Martin Schostak
    Mark Schrader
    Kurt Miller
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 343 - 349
  • [26] Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer
    CordonCardo, C
    Sheinfeld, J
    WORLD JOURNAL OF UROLOGY, 1997, 15 (02) : 112 - 119
  • [27] A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer
    Christoph, Frank
    Hinz, Stefan
    Kempkensteffen, Carsten
    Weikert, Steffen
    Krause, Hans
    Schostak, Martin
    Schrader, Mark
    Miller, Kurt
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (06) : 343 - 349
  • [28] Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy
    Segura-Pacheco, B
    Trejo-Becerril, C
    Perez-Cardenas, E
    Taja-Chayeb, L
    Mariscal, I
    Chavez, A
    Acuña, C
    Salazar, AM
    Lizano, M
    Dueñas-Gonzalez, A
    CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1596 - 1603
  • [29] Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms
    Qadi, Shahad A.
    Hassan, Mohammed A.
    Sheikh, Ryan A.
    Baothman, Othman A. S.
    Zamzami, Mazin A.
    Choudhry, Hani
    Al-Malki, Abdulrahman Labeed
    Albukhari, Ashwag
    Alhosin, Mahmoud
    EPIGENETICS INSIGHTS, 2019, 12
  • [30] Epigenetic reactivation of the DLC1 tumor suppressor protein is a new approach for cancer treatment
    Tripathi, Brajendra K.
    Boccuzzi, Luciarita
    Anderman, Meghan
    Qian, Xiaolan
    Walters, Kylie J.
    Doroshow, James H.
    Lowy, Douglas R.
    CANCER RESEARCH, 2020, 80 (16)
12345